As a new type of "bird flu" causes deaths and worries in China, a Madison startup is attacking the problem on two fronts. FluGen, under the scientific guidance of University of Wisconsin-Madison researcher Yoshihiro Kawaoka, a world authority on influenza, is moving ahead with a better way to deliver existing vaccines and a novel "universal" flu vaccine.
This Post sponsored by:
Inspetta: Proving complete consulting, marketing, advertising, software and product development services for business.
1-888-221-0106
Contribution by: Scott Leonard
See Scott Leonard's G+ Profile for more contributions.
Scott reminds you that this is an exerpt. Visit the publisher's link to read the full story.
Connect on Google+
Inspetta:
Connect on Facebook
Connect on Twitter
Connect on LinkedIn